Private Equity

Katten’s Health Care Services Deal Flow Event – Scott Davis will be attending the event on April 29 in Chicago.

Q1-2019 Private Equity Industry Update– Volatile public markets and political uncertainty are likely the cause of lower activity in Q1 2019 for both deal volume and capital invested. Due to the lack of investments, this is likely to leave a substantial amount of dry powder that can stimulate consolidation towards the end of the year.

BioScrip, Option Care Will Join Forces Within Infusion Market – Micheal Patton and Bill Bolding share some of their insight on the specialty pharmacy space with Radar on Specialty Pharmacy.

Current State of the DSO Market On Thursday April 25, Provident and Pepper Hamilton are co-hosting a webinar which will focus on private equity-led investment and consolidation activity within the dental sector. Please join us by registering for this complimentary webinar.

Long-Term Care Deals Dominate Health Industry in February – The long-term care sector continued its domination of health-care deals in February, Bloomberg Law’s transactions advisory board says.

‘Add-on Acquisition’ Deals in 2018 Were Key to PE Growth in Ophthalmology Sector, Report Finds – Consolidation activity within the ophthalmology sector remained very active through the fourth quarter of 2018, a year in which there were at least 10 transactions publicly disclosed in every quarter

Private Equity Interest in Hospice Acquisition Expected to Rise in 2019 – As more private equity firms enter the post-acute health care arena, hospice organizations are increasingly pursuing mergers and acquisitions as a growth strategy, according to the recently released 4th quarter 2018 Home Health & Hospice Update from Provident Healthcare Partners.

Healthcare Services M&A: A 2018 Recap and Expectations for 2019 – Episode 8 of Provident’s Healthcare Dealcast

The Health-Care M&A Meter: Hot 2018 to Be Followed by Hotter 2019– The outlook for health-care mergers and acquisitions in 2019 suggests even more transactions this year as compared to 2018, with activity in the hospital and health system sector expected to continue, as well as increasing volume of deals in the physician services, home health. and health-care IT sectors.

M&A Activity in Orthopedics, GI & More Increased in Q4 — 6 numbers to know– Physician specialties such as gastroenterology, orthopedics and urology saw an uptick in private equity consolidation activity in the fourth quarter of 2018, according to Provident Healthcare Partners.

Private Equity Investments in Orthopedics Expected to Surge in 2019 — Avoid these risks– Robert Aprill shares some insight as to why we should expect to see more private equity recapitalization transactions in orthopedics in 2019.

Health-Care Info Tech Companies Make Moves in November– Health-care information technology companies stole the deal spotlight in November, setting up end-of-year numbers rivaling those of the long-term care, physician practice, and health and hospital system sectors.

The Outlook is Bright for Orthopedic Investments, Analyst says: 4 Things to Know– The orthopedic space is a treasure trove of opportunity for private equity investors, according to Provident Healthcare Partners Analyst Robert Aprill.

What GI practices should look for in a PE partner — 5 Qs with Provident’s Abe M’Bodj– Abe M’Bodj shared insights into the gastroenterology private equity market with Becker’s ASC Review.

Q4-2018 Private Equity Industry Update– 2018 resulted in a strong year for private equity fund raising- the second highest fundraising year of all time. The strong deployment of capital has driven up valuation levels and created an even more attractive market for sellers. Despite volatile public market conditions, the outlook for valuations are expected to remain high in 2019.

Evaluating Transaction Considerations– AJ Shekar and Steven Grassa hosted a webinar “Evaluating Transaction Considerations” in partnership with the Association of Dermatology Administrators and Managers (ADAM).  The recording is now available.   

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”